简体中文 | 繁體中文 | English

Products & Services News

2016-01-05 10:19 Cellular Regenerative Therapy Greeted by French Minister of Health
2016-01-05 09:50 Segway Announces Expansion of Global Business Lines
2016-01-04 11:28 Herbalife Appoints Filipino Doctor to Its Nutrition Advisory Board
2015-12-30 18:02 3G Licensing S.A. Launches 3G Licensing Program
2015-12-30 11:54 Panasonic Develops a Stretchable Resin Film and Its Application Materials for Stretchable Electronics
2015-12-29 13:46 Mitsui Chemicals Participates in Subsidiary of Taiwan's Sentronic International Corp.
2015-12-28 17:08 Panasonic Large Screen Solutions -Enhance the Fan Experience
2015-12-28 13:38 CORRECTING and REPLACING Takeda Provides Further Information about Its New Business Venture with Teva
2015-12-28 09:58 Hyundai MOBIS Goes to CES, Armed with Cutting-edge Technology
2015-12-25 14:48 Furukawa Electric: Recycled Plastic Cable Trough Has Been Officially Approved by the UK Railway Network
2015-12-25 13:48 Weiler Corporation Acquires SWATYCOMET from Avtotehna
2015-12-24 17:40 Moody’s Honored with Top Industry Awards Throughout 2015
2015-12-24 12:03 High Profile Japanese Video Series "Dancing in the Four Seasons of Fukushima" Launched in 3 Languages!
2015-12-24 11:46 ACE Announces Future Leadership Team for Asia Pacific’s Property & Casualty Business
2015-12-24 09:50 Daniel Mark Harrison & Co. Pre-Sells One Fifth of Liverpool-Based White House Development in Deal to Chinese Bank
2015-12-23 16:17 UNESCO and Panasonic Launch Educational Support Programs for the Next Generation in Off-Grid Communities in Myanmar
2015-12-23 13:34 Panasonic to Start Production of Heat-Resistant Phenolic Molding Compounds for Automotive Parts in Ayutthaya, Thailand
2015-12-23 13:25 Panasonic Announces the Acquisition of Hussmann, a U.S.-Based Refrigerated, Freezer Display Case Manufacturer
2015-12-23 13:17 Boehringer Ingelheim Invests in Europe: Pharma Company Expands Biopharmaceutical Production at Vienna Site
2015-12-23 13:09 Merck and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab